Breast cancer detection tool from Parascript wins FDA nod

09/6/2013 | American City Business Journals

The FDA has granted Parascript approval for its AccuDetect software, designed to aid in early breast cancer diagnosis. In an analysis, the technology helped improve the detection of tumors missed in initial exams by 18.8% and achieved a 14.2% reduction in the number of follow-up tests from false positives, the company said.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC